Lakewood Ranch, FL, United States of America

Thomas M Estok

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 3.4

ph-index = 1


Location History:

  • Lakewood Ranch, FL (US) (2021)
  • Williamsburg, VA (US) (2024)

Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Thomas M Estok: Innovator in Cancer Treatment

Introduction

Thomas M Estok is a notable inventor based in Lakewood Ranch, Florida. He has made significant contributions to the field of cancer treatment, holding two patents that focus on innovative therapeutic methods. His work aims to improve the lives of patients suffering from various forms of cancer.

Latest Patents

Estok's latest patents include groundbreaking methods for treating cancer with TG02. The first patent outlines therapeutic methods for treating a cancer patient using TG02 in combination with a second therapeutic agent, such as an immune checkpoint inhibitor or a COX-2 inhibitor. The second patent focuses on the use of TG02 for treating gliomas in pediatric subjects, specifically targeting high-grade gliomas like diffuse intrinsic pontine glioma (DIPG) and H3.3-mutated gliomas. This patent also discusses pharmaceutical compositions and kits that include an ERK5 inhibitor, showcasing the innovative approaches Estok is taking in cancer therapy.

Career Highlights

Throughout his career, Thomas M Estok has worked with prominent organizations, including Cothera Bioscience, Inc. and the University of Pittsburgh. His experience in these institutions has allowed him to develop and refine his innovative ideas in cancer treatment.

Collaborations

Estok has collaborated with notable colleagues such as Eckard Weber and Tracy Lee Lawhon. These partnerships have contributed to the advancement of his research and the development of his patents.

Conclusion

Thomas M Estok is a pioneering inventor whose work in cancer treatment is making a significant impact. His innovative patents and collaborations highlight his commitment to improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…